Clinical Trials in Ohio

Showing 12541-12560 of 17,983 trials

A Study for Safety and Effectiveness of IMC-A12 by Itself or Combined With Antiestrogens to Treat Breast Cancer

NCT00728949

The purpose of this study is to determine whether IMC-A12 offers increased progression-free survival (PFS) associated with IMC-A12 monotherapy and IMC-A12 in combination with an antiestrogen therapy in patients with hormone receptor positive advanced or metastatic breast cancer that have experienced disease progression on antiestrogen therapy.

Metastatic Breast Cancer

Eli Lilly and Company93 participantsStarted Aug 2008

Scottsdale, Arizona, United States • Chicago, Illinois, United States • Westwood, Kansas, United States +6 more locations

COMPLETEDPhase 232 miles

Rituximab and Combination Chemotherapy in Treating Patients With Newly Diagnosed, HIV-Associated Burkitt's Lymphoma

NCT00392834

RATIONALE: Monoclonal antibodies, such as rituximab, can block cancer growth in different ways. Some block the ability of cancer cells to grow and spread. Others find cancer cells and help kill them or carry cancer-killing substances to them. Drugs used in chemotherapy work in different ways to stop the growth of cancer cells, either by killing the cells or by stopping them from dividing. Giving rituximab together with combination chemotherapy may kill more cancer cells. PURPOSE: This phase II trial is studying how well giving rituximab together with combination chemotherapy works in treating patients with newly diagnosed, HIV-associated Burkitt's lymphoma.

Lymphoma

AIDS Malignancy Consortium34 participantsStarted Sep 2006

La Jolla, California, United States • Los Angeles, California, United States • Los Angeles, California, United States +10 more locations

A Study for Safety and Effectiveness of IMC-A12 by Itself or Combined With Antiestrogens to Treat Breast Cancer

Rituximab and Combination Chemotherapy in Treating Patients With Newly Diagnosed, HIV-Associated Burkitt's Lymphoma

Find Trials by Condition in Ohio

Alisertib With and Without Rituximab in Treating Patients With Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma

A Trial of ABT-888 in Combination With Temozolomide Versus Pegylated Liposomal Doxorubicin Alone in Ovarian Cancer

A Phase 3 Study to Evaluate the Efficacy and Safety of Ivacaftor and VX-661 in Combination With Ivacaftor in Subjects Aged 12 Years and Older With Cystic Fibrosis, Heterozygous for the F508del-cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Mutation

Efficacy and Safety Study for Cognitive Deficits in Adult Subjects With Schizophrenia

Phase 1 Study of GRN-1201 in HLA-A*02 Subjects With Resected Melanoma

Immunogenicity and Safety of GSK Biologicals' Combined Measles-mumps-rubella Vaccine in Volunteers, Seven Years of Age and Older

Ofatumumab Subcutaneous Administration in Subjects With Relapsing-Remitting Multiple Sclerosis

Systematic Evaluation of Antiviral Medication in Schizophrenia

Dose Ranging Study of Brentuximab Vedotin in Adults With Lupus

Trial to Evaluate the Efficacy of GSK Biologicals' Influenza Vaccine GSK2186877A in Adults 65 Year of Age and Older

A Study of Tasisulam in Treating Participants With Malignant Melanoma

Methylphenidate (Ritalin) and Memory/Attention in Traumatic Brain Injury (TBI)

A Phase 3b Study of Erythropoietin Drugs Using a Specified Dosing Algorithm in Patients With Chronic Kidney Disease on Hemodialysis

A Study of Atrasentan on Reducing Albuminuria in Type 2 Diabetic Nephropathy Treated With Renin-Angiotensin System Inhibitors

Stimulant Versus Nonstimulant Medication for Attention Deficit Hyperactivity Disorder in Children

Evaluation of the Accuracy of an Implanted Glucose Sensor

Trial to Assess the Pharmacokinetics, Safety, Tolerability of Oral Brexpiprazole in Children (6 to <13 Years Old) With Central Nervous System Disorders

Interactive Telehealth for Pressure Ulcer Prevention After SCI